Reata Pharmaceuticals, Inc. (RETA) Reports Q4 Loss, Lags Revenue Estimates
28/2 14:05
Reata Pharmaceuticals, Inc. (RETA) came out with a quarterly loss of $2.35 per share versus the Zacks Consensus Estimate of a loss of $2.31. This compares to loss of $1.90 per share a year ago. These figures are adjusted for non-recurring items....